EN ▼

mRNA cancer vaccine

Experimental mRNA Vaccine Shows Promising Results in Preventing Melanoma Return

by

An experimental mRNA cancer drug has been found to stop the spread and return of melanoma for the first time, marking a potentially game-changing breakthrough for people suffering from life-threatening skin cancer. The personalized vaccine, known as intismeran, succeeded in preventing melanoma from coming back or spreading in patients who had undergone surgery to remove … Read more

Moderna and Merck Unveil Breakthrough mRNA Melanoma Vaccine Trial Success

by

A Milestone in Personalized Cancer Immunotherapy Pharmaceutical giants Moderna and Merck have jointly announced that their personalized mRNA cancer vaccine, Intismeran, significantly reduced the risk of recurrence and metastasis in melanoma patients. Tested alongside Merck‘s established immunotherapy drug Keytruda, the experimental vaccine successfully met its primary endpoints in a rigorous late-stage Phase 3 trial involving … Read more